Literature DB >> 25673690

Characterization and mechanism of stress-induced translocation of 78-kilodalton glucose-regulated protein (GRP78) to the cell surface.

Yuan-Li Tsai1, Yi Zhang1, Chun-Chih Tseng1, Ramunas Stanciauskas2, Fabien Pinaud3, Amy S Lee4.   

Abstract

Glucose-regulated protein (GRP78)/BiP, a major chaperone in the endoplasmic reticulum, is recently discovered to be preferably expressed on the surface of stressed cancer cells, where it regulates critical oncogenic signaling pathways and is emerging as a target for anti-cancer therapy while sparing normal organs. However, because GRP78 does not contain classical transmembrane domains, its mechanism of transport and its anchoring at the cell surface are poorly understood. Using a combination of biochemical, mutational, FACS, and single molecule super-resolution imaging approaches, we discovered that GRP78 majorly exists as a peripheral protein on plasma membrane via interaction with other cell surface proteins including glycosylphosphatidylinositol-anchored proteins. Moreover, cell surface GRP78 expression requires its substrate binding activity but is independent of ATP binding or a membrane insertion motif conserved with HSP70. Unexpectedly, different cancer cell lines rely on different mechanisms for GRP78 cell surface translocation, implying that the process is cell context-dependent.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cancer Cell Lines; Cell Surface Protein; Chaperone; Endoplasmic Reticulum Stress (ER Stress); GPI-anchored Proteins; GRP78/BiP; Imaging; Translocation

Mesh:

Substances:

Year:  2015        PMID: 25673690      PMCID: PMC4375463          DOI: 10.1074/jbc.M114.618736

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies.

Authors:  B Luo; A S Lee
Journal:  Oncogene       Date:  2012-04-16       Impact factor: 9.867

2.  Human heat shock protein 70 (Hsp70) as a peripheral membrane protein.

Authors:  Ajay K Mahalka; Thomas Kirkegaard; Laura T I Jukola; Marja Jäättelä; Paavo K J Kinnunen
Journal:  Biochim Biophys Acta       Date:  2014-01-28

3.  Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis.

Authors:  Ren Liu; Xiuqing Li; Wenming Gao; Yue Zhou; Shiuan Wey; Satyajit K Mitra; Valery Krasnoperov; Dezheng Dong; Shuanglong Liu; Dan Li; Genyuan Zhu; Stan Louie; Peter S Conti; Zibo Li; Amy S Lee; Parkash S Gill
Journal:  Clin Cancer Res       Date:  2013-09-18       Impact factor: 12.531

4.  ERdj3 regulates BiP occupancy in living cells.

Authors:  Feng Guo; Erik L Snapp
Journal:  J Cell Sci       Date:  2013-02-01       Impact factor: 5.285

5.  Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.

Authors:  Jagan M R Patlolla; Malisetty V Swamy; Jayadev Raju; Chinthalapally V Rao
Journal:  Oncol Rep       Date:  2004-05       Impact factor: 3.906

6.  The Escherichia coli subtilase cytotoxin A subunit specifically cleaves cell-surface GRP78 protein and abolishes COOH-terminal-dependent signaling.

Authors:  Rupa Ray; Gustaaf G de Ridder; Jerry P Eu; Adrienne W Paton; James C Paton; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

7.  Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.

Authors:  Yu Rebecca Miao; Bedrich L Eckhardt; Yuan Cao; Renata Pasqualini; Pedram Argani; Wadih Arap; Robert G Ramsay; Robin L Anderson
Journal:  Clin Cancer Res       Date:  2013-03-07       Impact factor: 12.531

8.  The natural human IgM antibody PAT-SM6 induces apoptosis in primary human multiple myeloma cells by targeting heat shock protein GRP78.

Authors:  Leo Rasche; Johannes Duell; Charlotte Morgner; Manik Chatterjee; Frank Hensel; Andreas Rosenwald; Hermann Einsele; Max S Topp; Stephanie Brändlein
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  EphB4 as a therapeutic target in mesothelioma.

Authors:  Ren Liu; Benjamin D Ferguson; Yue Zhou; Kranthi Naga; Ravi Salgia; Parkash S Gill; Valery Krasnoperov
Journal:  BMC Cancer       Date:  2013-05-30       Impact factor: 4.430

10.  Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production.

Authors:  Yi Zhang; Chun-Chih Tseng; Yuan-Li Tsai; Xiaoyong Fu; Rachel Schiff; Amy S Lee
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more
  65 in total

1.  Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-β signaling.

Authors:  Yuan-Li Tsai; Dat P Ha; He Zhao; Anthony J Carlos; Shan Wei; Tsam Kiu Pun; Kaijin Wu; Ebrahim Zandi; Kevin Kelly; Amy S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-13       Impact factor: 11.205

2.  Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions.

Authors:  Elizabeth D Crane; Ali A Al-Hashimi; Jack Chen; Edward G Lynn; Kevin Doyoon Won; Šárka Lhoták; Magda Naeim; Khrystyna Platko; Paul Lebeau; Jae Hyun Byun; Bobby Shayegan; Joan C Krepinsky; Katey J Rayner; Serena Marchiò; Renata Pasqualini; Wadih Arap; Richard C Austin
Journal:  JCI Insight       Date:  2018-12-20

3.  Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78.

Authors:  Debasis Nayak; Archana Katoch; Deepak Sharma; Mir Mohd Faheem; Souneek Chakraborty; Promod Kumar Sahu; Naveed Anjum Chikan; Hina Amin; Ajai Prakash Gupta; Sumit G Gandhi; Debaraj Mukherjee; Anindya Goswami
Journal:  Breast Cancer Res Treat       Date:  2019-06-07       Impact factor: 4.872

4.  Multi-omics profiling of calcium-induced human keratinocytes differentiation reveals modulation of unfolded protein response signaling pathways.

Authors:  Anna Michaletti; Mara Mancini; Artem Smirnov; Eleonora Candi; Gerry Melino; Lello Zolla
Journal:  Cell Cycle       Date:  2019-07-22       Impact factor: 4.534

5.  ER residential chaperone GRP78 unconventionally relocalizes to the cell surface via endosomal transport.

Authors:  Richard Van Krieken; Yuan-Li Tsai; Anthony J Carlos; Dat P Ha; Amy S Lee
Journal:  Cell Mol Life Sci       Date:  2021-05-11       Impact factor: 9.261

6.  NEU3 Sialidase Protein Interactors in the Plasma Membrane and in the Endosomes.

Authors:  Federica Cirillo; Andrea Ghiroldi; Chiara Fania; Marco Piccoli; Enrica Torretta; Guido Tettamanti; Cecilia Gelfi; Luigi Anastasia
Journal:  J Biol Chem       Date:  2016-03-17       Impact factor: 5.157

Review 7.  HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum.

Authors:  Jie Wang; Jessica Lee; David Liem; Peipei Ping
Journal:  Gene       Date:  2017-03-07       Impact factor: 3.688

8.  Endoplasmic Reticulum Chaperone GRP78 Protects Heart From Ischemia/Reperfusion Injury Through Akt Activation.

Authors:  Xukun Bi; Guangyu Zhang; Xiaoding Wang; Chau Nguyen; Herman I May; Xiaoting Li; Ali A Al-Hashimi; Richard C Austin; Thomas G Gillette; Guosheng Fu; Zhao V Wang; Joseph A Hill
Journal:  Circ Res       Date:  2018-04-18       Impact factor: 17.367

Review 9.  Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.

Authors:  Yangyang Wang; Xinhui Wang; Cristina R Ferrone; Joseph H Schwab; Soldano Ferrone
Journal:  Mol Oncol       Date:  2015-10-30       Impact factor: 6.603

10.  AR-12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication.

Authors:  Laurence Booth; Jane L Roberts; Heath Ecroyd; Sarah R Tritsch; Sina Bavari; St Patrick Reid; Stefan Proniuk; Alexander Zukiwski; Abraham Jacob; Claudia S Sepúlveda; Federico Giovannoni; Cybele C García; Elsa Damonte; Javier González-Gallego; María J Tuñón; Paul Dent
Journal:  J Cell Physiol       Date:  2016-06-06       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.